Elicio Therapeutics, Inc.
ELTX
Revenue
0.00
0.000.00%
6 Months ChangeAssets
15.75M
▼-8.73M▼-35.66%
3 Months ChangeLiabilities
17.40M
▼-2.21M▼-11.26%
3 Months ChangeFree Cash Flow
-12.12M
▼-3.97M▼-48.63%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-17
Form 8-K
ID: 0001601485-24-000057
2024-08-30
Form 8-K
ID: 0001140361-24-039592
2024-08-13
Form 10-Q
ID: 0001601485-24-000045
2024-08-13
Form 8-K
ID: 0001601485-24-000042
2024-08-12
Form 8-K
ID: 0001140361-24-036848
2024-07-01
Form 8-K
ID: 0001140361-24-031811
2024-06-27
Form 8-K
ID: 0001140361-24-031563
2024-05-24
Form 8-K
ID: 0001601485-24-000037
2024-05-15
Form 10-Q
ID: 0001601485-24-000033
2024-05-15
Form 8-K
ID: 0001601485-24-000032